Michel Delforge, MD, PhD, is a physician at the Department of Hematology of University Hospital Leuven, Leuven, Belgium. Prof. Delforge received his medical degree from the Catholic University of Leuven, and completed his residency in Internal Medicine at the University Hospital Gasthuisberg, Leuven and Imelda Ziekenhuis, Bonheiden. In 1998, he obtained a PhD from the Catholic University of Leuven. Besides being a physician, Prof. Delforge is also a professor of medicine and the clinical Head of Hematology at University Hospital Leuven.
Speaking on the treatment and management of multiple myeloma
Prof. Delforge focuses on the treatment and management of multiple myeloma and plasma cell disorders. He is a member of the executive committee (center of excellence) of the Stem Cell Institute Leuven, and also a member of the CTG (commission for drug reimbursement of the national health insurance).